Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05416138 · ClinicalTrials.gov registry record · NA
Theta Phase-specific TMS to Modulate Prefrontal Activity
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT05416138 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 26 participants.
The verdict
NCT05416138, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the causal link between the phase of ongoing theta oscillations in the prefrontal cortex and approach/avoidance (Ap/Av) behavior in adults using theta phase-specific transcranial magnetic stimulation (TMS).
Interventions
- DEVICE Transcranial magnetic stimulation (TMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05416138
The ClinicalTrials.gov registry entry for NCT05416138 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial magnetic stimulation (TMS) is the first listed.
NCT05416138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05416138 about?
NCT05416138 is a clinical study titled "Theta Phase-specific TMS to Modulate Prefrontal Activity". The purpose of this study is to evaluate the causal link between the phase of ongoing theta oscillations in the prefrontal cortex and approach/avoidance (Ap/Av) behavior in adults using theta phase-specific transcranial magnetic stimulation (TMS).
What is the current status of trial NCT05416138?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-11-01. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT05416138?
The interventions under investigation include: Transcranial magnetic stimulation (TMS) (DEVICE).
Who is sponsoring clinical trial NCT05416138?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.